INDOUS NSI Week ended 07 Aug 2026

Weekly Investor Report

Indo Us Bio-Tech Limited · Basic Materials · Agricultural Inputs

Latest close 81.65 INR
0.0% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -22.3% below the Trend Line and sits at 2.1% of its 52-week range. The latest completed week returned 0.0%, after a -6.7% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100.

Setup score 19 out of 100
Latest Close 81.65 INR 7 Aug 2026
1W Return 0.0% latest completed week
4W Return -6.7% short-term follow-through
12W Return -22.4% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 1.5x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -22.3% below the Trend Line and sits at 2.1% of its 52-week range. The latest completed week returned 0.0%, after a -6.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0012-week average 0.02

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.00Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -6.7% over four weeks, -22.4% over 12 weeks, and -52.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W0.0%
4W-6.7%
12W-22.4%
26W-35.2%
52W-52.0%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.27Latest activity-pressure read.
Pressure change-4.7%Four-week change in activity pressure.
Leadership-29.74Latest relative-leadership reading.
RS change-7.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 88% Model confidence 82%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength58/100Blend of value, momentum, and quality. Underlying universe rank 43; rank 1 is best.
Value53/100Relative valuation strength. Underlying universe rank 48; rank 1 is best.
Quality52/100Profitability and accounting quality. Underlying universe rank 49; rank 1 is best.
Momentum54/100Medium-term price momentum. Underlying universe rank 47; rank 1 is best.
Growth52/100Revenue and earnings growth. Underlying universe rank 49; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework78/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
12.5x
Price divided by trailing earnings.
Price / sales
1.5x
Market value relative to trailing revenue.
EV / EBITDA
11.4x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-7.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
27.3%
Gross profit retained from each unit of revenue.
Operating margin
14.6%
Operating profit retained from revenue.
Free-cash-flow margin
-13.6%
Free cash flow generated from revenue.
Return on invested capital
9.8%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
6.4%
Latest one-year revenue growth.
EPS growth
-19.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-2790.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 0 relevant articles.

0 positive · 0 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-53.1%Distance below the 52-week high.
13-week volatility2.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+14.1%Week of 20 Feb.
Worst week-21.5%Week of 6 Mar.
Latest week+0.0%Week of 7 Aug.

Shape of recent returns

Strong gains4
Modest gains7
Flat weeks0
Modest losses8
Sharp losses7
Recent vol2.8%13-week weekly-return volatility.
Base vol5.9%52-week weekly-return volatility.
Up/down split20/32Count of positive and negative weeks in the 52-week window.
Average skew3.9% / -4.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202681.65 INR0.0%105.1 INR161.3 INR-1.27-29.74116.0KOff
31 Jul 202681.62 INR-4.0%106.2 INR162.1 INR-1.22-30.27121.0KOff
24 Jul 202684.98 INR-2.6%107.5 INR162.9 INR-1.23-26.56151.5KOff
17 Jul 202687.28 INR-0.3%108.8 INR163.7 INR-1.26-27.22197.8KOff
10 Jul 202687.52 INR-1.8%110.0 INR164.6 INR-1.22-27.78168.1KOff
3 Jul 202689.15 INR0.5%111.3 INR165.4 INR-1.25-27.342.8KOff
26 Jun 202688.75 INR-2.7%112.7 INR166.2 INR-1.15-27.700Off
19 Jun 202691.21 INR2.3%114.2 INR167.1 INR-1.02-26.2012.6KOff
12 Jun 202689.17 INR-8.7%115.3 INR167.9 INR-0.92-27.2713.9KOff
5 Jun 202697.70 INR-2.1%116.6 INR168.8 INR-0.75-20.2244.7KOff
29 May 202699.80 INR-1.1%117.8 INR169.6 INR-0.63-19.8349.0KOff
22 May 2026100.9 INR-4.1%119.0 INR170.4 INR-0.57-20.2781.7KOff
15 May 2026105.2 INR-6.0%120.3 INR171.2 INR-0.56-17.1367.1KOff
8 May 2026112.0 INR7.4%120.9 INR172.0 INR-0.54-14.23104.2KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context